The Psoriasis Mandate
Sign our petition for the rights of people with psoriasis!
The Psoriasis Mandate is an online petition highlighting 5 key rights of people with psoriasis.
In June 2012, a Psoriasis White Paper was published, providing policy-makers and health professionals with a framework to improve the care of people with psoriasis across Europe.
By signing the Psoriasis Mandate, you are showing your support for these recommendations to be acted on and calling for improved standards of care for each and every person living with psoriasis in Europe today.
The Psoriasis White Paper and the Psoriasis Mandate are supported by Janssen, more specifically Janssen Pharmaceutica NV, Belgium.
Thank you for your support.
- Chair, The Expert European Working
- Group for Healthcare in Psoriasis
- Centre for Dermatological Research
- University Clinics of Hamburg
- Germany
- President, The European Umbrella Organisation
- for Psoriasis Movements (EUROPSO)
Privacy Notice
By contributing to this petition via our website, which will require that you provide personal data, you are giving your express consent to Janssen Pharmaceutica, NV to incorporate this data to a database and to process the personal data with the purpose of demonstrating the scale of support for the rights of people living with psoriasis. This will be demonstrated in the form of a signed petition presented to European policy-makers. A press release highlighting the numbers of signatures on the petition will be delivered to European media. However, no personal data will be disclosed.
You also agree that the personal data collected through the questionnaire can be shared with third parties for the purposes of processing and storing, with whom we have entered into the appropriate processing agreements and with the different subsidiaries of our company, Johnson & Johnson, pertaining to the investigation and medicine sector, for the above described purposes and subject to the terms of the present Privacy Notice. As a consequence, the personal data you provide can be transferred to countries outside of the European Economic Area, like, for example, the US, in which the European Union has declared that they lack an appropriate legislation guaranteeing an adequate level of protection. However, Janssen Pharmaceutica, NV and the subsidiaries of the Johnson & Johnson group of companies, as well as any third parties involved, will apply the appropriate safeguards for the protection of your personal data. Once the petition is closed (more specifically after presentation of the petition to the European Parliament and the issuing of a press release to European media), all data will be discarded.
At any time, you can exercise your rights of access, rectification, cancellation or opposition by contacting Janssen.
For more information, please read the Privacy Policy of the Psoriasis360 website. 
